Alpha Cognition Inc.ACOGEarnings & Financial Report
Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| John Havens | 2.00% | 319.2K | ▼ -3.30pp | 2024-11-15 |
Insider Transactions
Net 90d: +$2.13M · buys $2.13M / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-16 | Bethany Sensenig | Director | Grant | 5.5K | $0.00 | $0 |
| 2026-03-30 | Opaleye Management Inc. | 10% Owner | Buy (open market) | 1.9K | $4.99 | $9.2K |
| 2026-03-27 | Opaleye Management Inc. | 10% Owner | Buy (open market) | 10.0K | $5.08 | $50.8K |
| 2026-03-26 | Opaleye Management Inc. | 10% Owner | Buy (open market) | 7.3K | $5.28 | $38.7K |
| 2026-03-25 | Opaleye Management Inc. | 10% Owner | Buy (open market) | 8.6K | $5.43 | $46.6K |
| 2026-03-24 | Opaleye Management Inc. | 10% Owner | Buy (open market) | 4.2K | $5.59 | $23.4K |
| 2026-03-19 | Opaleye Management Inc. | 10% Owner | Buy (open market) | 2.1K | $5.71 | $12.0K |
| 2026-03-18 | Opaleye Management Inc. | 10% Owner | Buy (open market) | 2.5K | $5.75 | $14.3K |
| 2026-03-16 | Opaleye Management Inc. | 10% Owner | Buy (open market) | 1.3K | $5.78 | $7.7K |
| 2026-03-13 | Opaleye Management Inc. | 10% Owner | Buy (open market) | 7.4K | $5.75 | $42.3K |
1–10 of 27
Page 1 / 3